Skip to main content
Premium Trial:

Request an Annual Quote

Vasudev Rangadass

L7 Informatics (formerly Lab7 Systems) has named Vasudev Rangadass as its CEO. Rangadass joined the company from NantHealth, where he served as chief strategy officer following NantHealth's acquisition of Net.Orange, a company Rangadass founded to provide enterprise solutions to the healthcare industry. Prior to Net.Orange he was the first employee of i2 Technologies.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.